Connect with us

Business

AdAlta (ASX:1AD) share price rockets 31% on United States FDA update

Published

on

The AdAlta Ltd (ASX:1AD) share price is rocketing today following the positive news on its drug trials. In mid-morning trade, the biotech company’s share price is soaring 31.4% higher to 23 cents.

However, at the time of writing, the AdAlta share price has retreated slightly to 20 cents, up 14.29%. Also, it’s worth noting that the AdAlta share price reached a 52-week high of 26.5 cents in the opening minutes of trade.

Quick take on AdAlta

Established in 2006, AdAlta is a clinical-stage biotechnology company. The company’s focus is on researching and developing protein-based therapies. Thus, AdAlta utilises a range of unique compounds, known as i-bodies, to create a pipeline of drugs to treat serious diseases. This includes…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Elon Musk says he wants to create a city in Texas called ‘Starbase’ – Stuff.co.nz
Article feature image
Qld claims it’s being ‘picked on’ in bizarre health department tweet about vaccine rollout – NEWS.com.au